While the trade is happening worldwide, there is a particular shortage in Britain, which has only a small number of positive COVID-19 blood samples, public health officials said, because it was slow to roll out testing. Traditionally, blood samples have been provided at low cost by Britain’s largely centralised public health system to labs and clinics. Strict rules govern the collection and use of human samples in the country, banning the payment of donors (past a small expense fee) and prohibiting third parties from making a profit from blood samples sourced from the National Health Service. Some of Cantor BioConnect’s blood samples are reasonably priced for the US market, industry experts said. It said it had not yet sold any of the Cantor BioConnect samples.

Source: bd News24 May 02, 2020 03:11 UTC